97
Participants
Start Date
November 14, 2007
Primary Completion Date
March 25, 2014
Study Completion Date
July 27, 2018
Polyphenon E
Polyphenon E, at a dose of 400 mgs EGCG (200 mgs BID) for 1 year in men diagnosed with HGPIN and ASAP.
Placebo
Matching placebo BID
Jefferson Medical College - Department of Urology, Philadelphia
University of Florida - Jacksonville, Jacksonville
University of Florida/Shands-Department of Urology, Gainesville
H Lee Moffitt Cancer Center, Tampa
James A Haley VA, Tampa
Watson Clinic Center for Research, Inc., Lakeland
Minneapolis VA Medical Center, Minneapolis
University of Chicago - Department of Surgery, Chicago
LSU Health Sciences Center, Feist-Weiller Cancer Center, Shreveport
Overton Brooks VA Medical Center, Shreveport
National Cancer Institute (NCI)
NIH
H. Lee Moffitt Cancer Center and Research Institute
OTHER